BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14664733)

  • 1. Integrative tumor board: recurrence of ovarian cancer.
    Knaus JV; Bugno T; Nathan D; Lagomarcino N; Labriola D; Block PB; Alvarado C; Chamness A; Block KI
    Integr Cancer Ther; 2002 Dec; 1(4):392-416. PubMed ID: 14664733
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrative tumor board: recently diagnosed lung cancer.
    de la Torre M; Stolbach L; Fulop JA; Grotto D; Sagar SM; Hidenbrand G; Block KI
    Integr Cancer Ther; 2002 Sep; 1(3):246-65. PubMed ID: 14667283
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrative tumor board: Advanced breast cancer.
    Kut V; Boasberg P; Sagar S; Miller S; Birdsall TC; Rey S; Martin J; Rogers M; Wicke RW; Cheung CS; He B; Chen K; Hovi MA; Dreher H; McCray P; Block KI
    Integr Cancer Ther; 2002 Jun; 1(2):179-214. PubMed ID: 14664744
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrative tumor board: Esophageal cancer.
    de la Torre M; Bugno TJ; Gustin DM; Motwani B; Nathan D; Fulop JA; Augustine M; Lo CH; Yance DR; Krost B; Devi NJ; Little S; Block KI
    Integr Cancer Ther; 2002 Mar; 1(1):44-66. PubMed ID: 14664748
    [No Abstract]   [Full Text] [Related]  

  • 5. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
    Goff BA
    Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer.
    Hernando JJ; Park TW; Fischer HP; Zivanovic O; Braun M; Pölcher M; Grünn U; Leutner C; Pötzsch B; Kuhn W
    Lancet Oncol; 2007 May; 8(5):451-4. PubMed ID: 17466904
    [No Abstract]   [Full Text] [Related]  

  • 7. Is micropapillary serous carcinoma for real?
    Gershenson DM
    Cancer; 2002 Aug; 95(4):677-80. PubMed ID: 12209709
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare case of serous papillary cystadenocarcinoma of the testis.
    Leonardo C; Franco G; Michetti M; De Nunzio C; Zampelli A; De Dominicis C
    J Androl; 2010; 31(5):434-6. PubMed ID: 20133965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin metastases revealing a bilateral ovarian invasive micropapillary serous carcinoma.
    Moussa A; Denguezli W; Njim L; Haddad A; Faleh R; Sakouhi M; Zakhama A
    Arch Gynecol Obstet; 2008 Jul; 278(1):71-4. PubMed ID: 18066568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous regression in recurrent epithelial ovarian cancer.
    Fujiwaki R; Sawada K
    Arch Gynecol Obstet; 2007 May; 275(5):389-91. PubMed ID: 17177031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors).
    Seidman JD; Kurman RJ
    Cancer; 2002 Aug; 95(4):675-6. PubMed ID: 12209708
    [No Abstract]   [Full Text] [Related]  

  • 13. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
    Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategy and outcome of interdisciplinary therapy of ovarian carcinomas].
    Ruf C; Kohlberger E; Bauknecht T; Farthmann EH
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1494-6. PubMed ID: 9931922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
    Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
    Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of radiotherapy for state I ovarian carcinoma].
    Sheng X; Sun J; Zhou C
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian carcinoma relapsing as a cerebellopontine angle tumour.
    Geetha N; James FV; Ramachandran K; Ajithkumar TV; Nair MK
    Australas Radiol; 1999 Aug; 43(3):388-90. PubMed ID: 10901945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
    Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
    Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.